November 18, 2021
Nordic Nanovector ASA: Results for the Third Quarter 2021
Media
November 15, 2021
Spruce Biosciences Reports Third Quarter 2021 Financial Results and Provides Corporate Updates
November 15, 2021
Spruce Biosciences Appoints Mike Grey as Interim CEO
November 15, 2021
Jakob Lindberg appointed CEO of Oncopeptides
November 12, 2021
Carisma Therapeutics Presents Data from Phase I Clinical Trial of CT-0508, A HER2 Targeted CAR-Macrophage
November 10, 2021
Xeris Biopharma Reports Third Quarter 2021 Financial Results and Other Highlights
November 09, 2021
Nordic Nanovector supports The Health Policy Partnership’s initiative to improve appropriate readiness for radioligand therapy (radioimmunotherapy) in lymphoma
November 09, 2021
Fusion Pharmaceuticals Announces Third Quarter 2021 Financial Results And Clinical Program Update
November 09, 2021
Targovax announces two posters at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 08, 2021
Aprea Therapeutics Reports Third Quarter 2021 Financial Results and Provides Update on Business Operations